Redesigning Diabetes Care for Treatment Inertia: A Population Health Model

Area of Science:

• Endocrinology
• Health Services Research
• Primary Care Medicine

Background:

• Despite advances in diabetes management, many patients exceed glycemic targets due to factors like therapeutic inertia and limited specialist access.
• Existing treatment guidelines and algorithms have not fully resolved the challenge of achieving optimal blood glucose control in diabetes patients.
• Healthcare systems face challenges in integrating complex clinical practice guidelines and managing time constraints in diabetes care.

Purpose of the Study:

• To introduce and evaluate a novel care model designed to overcome barriers in diabetes management.
• To improve glycemic control and address cardiometabolic risk by fostering collaboration between diabetes specialty teams and primary care providers (PCPs).
• To assess the impact of a collaborative care model on hemoglobin A1c (HbA1c) levels and provider workload.

Main Methods:

• A collaborative care model was implemented, involving a diabetes specialty team and PCPs.
• The intervention utilized electronic medical records (EMR) to review patient data and deliver personalized, evidence-based recommendations to providers.
• Diabetes education and other health system resources were integrated to optimize patient care and cardiometabolic risk management.

Main Results:

• The intervention resulted in a significant decrease in mean hemoglobin A1c (HbA1c) by nearly 1% post-intervention.
• Over half of the patient cohort (52.1%) achieved a reduction of at least 0.5% in HbA1c.
• Team-based approaches were most effective, demonstrating successful resource utilization without increasing the burden on primary care or specialty teams.

Conclusions:

• The novel collaborative care model effectively improved glycemic control in patients with diabetes.
• Team-based strategies integrating specialty consultants and primary care providers are crucial for optimizing diabetes management.
• This model offers a sustainable solution for addressing the growing diabetes epidemic and specialist shortages, contingent on payer support.